SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
China SXT Pharmaceuticals, Inc.
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026
$0.11+0.05 (+71.08%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 10, 2026 | 1-for-80 reverse | Earlier per-share figures multiplied by 80 |
| Feb 3, 2026 | 1-for-150 reverse | Earlier per-share figures multiplied by 150 |
| Oct 5, 2023 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Aug 13, 2021(first seen in filings) | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Feb 22, 2021 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |